Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07094945Phase 4Not yet recruiting
A Phase 4 trial of remimazolam, sponsored by Tongji Hospital. Planned start Aug 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07094945.